The global Blood Glucose Meter market is likely to expand considerably in the coming years due to advent of non-invasive devices. According to a report published by Fortune Business Insights, titled “Blood Glucose Meter: Global Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at US$ 7,419.0 Mn in 2018. Fortune Business Insights states that this market is likely to reach US$ 15,415.6 Mn by 2026, thereby exhibiting a CAGR of 9.6%.
some of the key players in the global Blood Glucose Meter Market:
- Hoffmann-La Roche Ltd
- Dexcom, Inc.
- Braun Melsungen AG
- Lifespan Inc.
- Ascensia Diabetes Care Holdings AG.
- Terumo Medical Corporation
- DiaMonTech GmbH.
In this report, Fortune Business Insights has indicated that the market will grow in the near future due to the increasing demand and the subsequently rising uptake of blood glucose meters. Increasing incidence of diabetes has been a leading factor that is responsible for the surge in demand of blood glucose meters. According to the International Diabetes Federation (IDF), in 2017, around 425 million people suffered from diabetes, worldwide. Furthermore, it also states that this number is likely to reach 629 million by the year 2045. High prevalence of diabetes, combined with the accuracy of digital Blood Glucose Meter in detecting blood pressure and sugar levels are driving the global Blood Glucose Meter market.
Launch of DiaMonTech’s IR-based Blood Glucose Meter to Spur Growth Opportunities
Conventional Blood Glucose Meter involved the need for invasive techniques for diagnosis. The most commonly used methods involved taking blood samples with the help of needle pricks in fingers. The needle prick method was painful for many users and it caused discomfort to some. Therefore, there has been a constant need for an alternative to the invasive devices for continuous glucose monitoring. In 2018, DiaMonTech announced the launch of a compact blood glucose meter. The device performed on an infra-red technology that is used to count the glucose molecules. This product is likely to transform existing blood glucose monitoring techniques and is likely to witness high demand from around the world. The advent of non-invasive devices is likely to induce growth in the global Blood Glucose Meter market.
LifeScan and Sanvita Medical Collaborate to Develop Continuous Glucose Monitoring Devices
In May 2019, LifeScan announced that it has reached an agreement with Sanvita Medical for development and marketing of continuous glucose monitoring (CGM) devices. Through this agreement, the company aims at making CGM devices available throughout North America and certain parts of Europe in initial years, with an aim of expanding in other parts of the world in the coming years. The company boasts an attractive product portfolio and its latest addition of CGM devices will bode well for the future business expansion. This partnership will have a positive impact on the global market and is likely to favor growth of the market in the coming years
More Trending Topics from Fortune Business Insights: